Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Immunol. 2019 Mar 27;202(9):2585–2608. doi: 10.4049/jimmunol.1801350

Table II.

Demographic and clinical characteristics of the study population for immunophenotyping of activated T cells

TNL
(n=20)
TIL
(n=37)
PTNL
(n=18)
PTL
(n=53)
p value
Age (y; median [IQR])a 24 (22-30.3) 26 (22-31) 30 (26-33) 24 (20-29) 0.02
Body mass index (kg/m2; median [IQR])a 33.7 (27.2-37.1) 28.5 (24.2-35.6) 27.8 (24-35.4) 26.4 (21.5-31.3) NS
Gestational age at delivery (wk; median [IQR])a 39 (38.8-39.3) 38.9 (38.3-39.4) 33.4 (30.5-34.4) 34.9 (33.9-35.7) <0.001
Birth weight (g; median [IQR])a 3355 (2872.5-3511.3) 3185 (2735-3495) 1420 (1205.3-2095) 2255 (1830-2540) <0.001
Race (n[%])b NS
 African-American 15 (75%) 35 (94.6%) 12 (66.6%) 46 (86.8%)
 Caucasian 3 (15%) 1 (2.7%) 4 (22.2%) 5 (9.4%)
 Hispanic 0 (0%) 0 (0%) 0 (0%) 0 (%)
 Asian 1 (5%) 0 (0%) 1 (5.6%) 0 (%)
 Other 1 (5%) 1 (2.7%) 1 (5.6%) 2 (3.8%)
Primiparity (n[%])b 0 (0%) 10 (27%) 3 (16.7%) 14 (26.4%) 0.03
Cesarean section (n[%])b 20 (100%) 4 (10.8%) 18 (100%) 12 (22.6%) <0.001
a

Kruskal-Wallis test;

b

Fisher’s exact test;

IQR = interquartile range, TNL = term no labor, TIL = term in labor, PTNL = preterm no labor, PTL = preterm in labor